Your browser doesn't support javascript.
loading
Rollout of Closed-Loop Technology to Pregnant Women with Type 1 Diabetes: Healthcare Professionals' Views About Potential Challenges and Solutions.
Rankin, David; Hart, Ruth I; Kimbell, Barbara; Barnard-Kelly, Katharine; Brackenridge, Anna; Byrne, Caroline; Collett, Corinne; Dover, Anna R; Hartnell, Sara; Hunt, Katharine F; Lee, Tara T M; Lindsay, Robert S; McCance, David R; McKelvey, Alastair; Rayman, Gerry; Reynolds, Rebecca M; Scott, Eleanor M; White, Sara L; Hovorka, Roman; Murphy, Helen R; Lawton, Julia.
Afiliación
  • Rankin D; Usher Institute, Medical School, University of Edinburgh, Edinburgh, United Kingdom.
  • Hart RI; Usher Institute, Medical School, University of Edinburgh, Edinburgh, United Kingdom.
  • Kimbell B; Usher Institute, Medical School, University of Edinburgh, Edinburgh, United Kingdom.
  • Barnard-Kelly K; R&D, Moor Green Hospital, Southampton, United Kingdom.
  • Brackenridge A; Department of Diabetes and Endocrinology, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
  • Byrne C; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
  • Collett C; Norwich Clinical Trials Unit, Norwich Medical School, University of East Anglia, Norwich, United Kingdom.
  • Dover AR; Edinburgh Centre for Endocrinology and Diabetes, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom.
  • Hartnell S; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
  • Hunt KF; Diabetes Research Offices, Weston Education Centre, King's College Hospital NHS Foundation Trust, London, United Kingdom.
  • Lee TTM; Norwich Medical School, University of East Anglia, Norwich, United Kingdom.
  • Lindsay RS; Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich, United Kingdom.
  • McCance DR; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.
  • McKelvey A; Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital Belfast, Belfast, Northern Ireland.
  • Rayman G; Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich, United Kingdom.
  • Reynolds RM; The Diabetes Centre, Ipswich Hospital, East Suffolk and North Essex Foundation Trust, Ipswich, United Kingdom.
  • Scott EM; Edinburgh Centre for Endocrinology and Diabetes, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom.
  • White SL; Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.
  • Hovorka R; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.
  • Murphy HR; Department of Diabetes and Endocrinology, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
  • Lawton J; Department of Women and Children's Health, King's College London, London, United Kingdom.
Diabetes Technol Ther ; 25(4): 260-269, 2023 04.
Article en En | MEDLINE | ID: mdl-36662589
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 Tipo de estudio: Guideline Aspecto: Ethics Límite: Female / Humans / Pregnancy Idioma: En Revista: Diabetes Technol Ther Asunto de la revista: ENDOCRINOLOGIA / TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 Tipo de estudio: Guideline Aspecto: Ethics Límite: Female / Humans / Pregnancy Idioma: En Revista: Diabetes Technol Ther Asunto de la revista: ENDOCRINOLOGIA / TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos